The Coalition for Epidemic Preparedness Innovations (CEPI) was founded as a public-private coalition with the core mission of accelerating the development of vaccines and other biologic countermeasures to prevent and contain infectious disease epidemics. Headquartered in Washington, D.C., CEPI serves communities worldwide by coordinating and financing the development of new vaccines, focusing on epidemic and pandemic threats.

CEPI has garnered support from notable global health organizations and investors, including the Nuclear Threat Initiative (NTI). Among its key achievements is the launch of the Bio Funders Compact, aimed at integrating biosecurity into life science research funding. CEPI's impact is significant in the global health landscape, enhancing preparedness for future pandemics through innovative vaccine development and strategic partnerships.